Brief: Intervacc Awarded Funding From Vinnova For Further Development Of Vaccine Against Staphylococcus Aureus Infections
26/03/2020 24:58
March 25 (Reuters) - Intervacc AB IVACC.ST :
* INTERVACC AWARDED FUNDING FROM VINNOVA FOR FURTHER
DEVELOPMENT
OF VACCINE AGAINST STAPHYLOCOCCUS AUREUS INFECTIONS
* PROJECT WILL BE CO-FINANCED BY CO AND VINNOVA
* FINANCING COVERS A PART OF PRECLINICAL PHASE OF
DEVELOPMENT
PROGRAM WITH A BUDGET OF SEK 3.9 MILLION
Source text for Eikon: ID:nWkr8KNtmj
Further company coverage: IVACC.ST
((Reuters.Briefs@thomsonreuters.com;))